Walgreens Boots Alliance WBA has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 1 | 5 | 0 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 1 | 0 | 0 | 0 |
3M Ago | 0 | 0 | 4 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $26.67, a high estimate of $30.00, and a low estimate of $25.00. This current average represents a 11.1% decrease from the previous average price target of $30.00.
Breaking Down Analyst Ratings: A Detailed Examination
An in-depth analysis of recent analyst actions unveils how financial experts perceive Walgreens Boots Alliance. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Daniela Bretthauer | HSBC | Announces | Hold | $27.00 | - |
Lisa Gill | JP Morgan | Raises | Overweight | $30.00 | $27.00 |
Ben Hendrix | RBC Capital | Lowers | Sector Perform | $26.00 | $29.00 |
David Macdonald | Truist Securities | Lowers | Hold | $25.00 | $30.00 |
Ann Hynes | Mizuho | Lowers | Neutral | $25.00 | $31.00 |
Lisa Gill | JP Morgan | Lowers | Neutral | $27.00 | $33.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Walgreens Boots Alliance. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Walgreens Boots Alliance compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for Walgreens Boots Alliance's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Walgreens Boots Alliance's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on Walgreens Boots Alliance analyst ratings.
All You Need to Know About Walgreens Boots Alliance
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the U.S., with over 8,500 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the U.S. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
Key Indicators: Walgreens Boots Alliance's Financial Health
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Over the 3 months period, Walgreens Boots Alliance showcased positive performance, achieving a revenue growth rate of 9.16% as of 31 August, 2023. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Staples sector.
Net Margin: Walgreens Boots Alliance's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -0.51%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Walgreens Boots Alliance's ROE excels beyond industry benchmarks, reaching -0.88%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Walgreens Boots Alliance's ROA stands out, surpassing industry averages. With an impressive ROA of -0.18%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Walgreens Boots Alliance's debt-to-equity ratio stands notably higher than the industry average, reaching 1.67. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
Analyst Ratings: Simplified
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.